TCL Archive More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene August 28, 2009
TCL Archive Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies June 25, 2010
TCL Archive Cooperative Groups Advised to Prepare for 10 Percent Budget Cut, Begin Slowing Patient Accrual. Groups Say Cuts Would Jeopardize Clinical Trials Program. October 27, 2006